Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1–7) in regulation of cardiovascular function

American Journal of Physiology - Heart and Circulatory Physiology - Tập 289 Số 6 - Trang H2281-H2290 - 2005
Carlos M. Ferrario1, Aaron J. Trask2, Jewell A. Jessup2
1Hypertension and Vascular Disease Center, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA.
2The Hypertension and Vascular Disease Center, Wake Forest University School of Medicine, Winston Salem, North Carolina

Tóm tắt

Angiotensin-converting enzyme 2 (ACE2) is the first human homologue of ACE to be described. ACE2 is a type I integral membrane protein that functions as a carboxypeptidase, cleaving a single hydrophobic/basic residue from the COOH-terminus of its substrates. Because ACE2 efficiently hydrolyzes the potent vasoconstrictor angiotensin II to angiotensin (1–7), this has changed our overall perspective about the classical view of the renin angiotensin system in the regulation of hypertension and heart and renal function, because it represents the first example of a feedforward mechanism directed toward mitigation of the actions of angiotensin II. This paper reviews the new data regarding the biochemistry of angiotensin-(1–7)-forming enzymes and discusses key findings such as the elucidation of the regulatory mechanisms participating in the expression of ACE2 and angiotensin-(1–7) in the control of the circulation.

Từ khóa


Tài liệu tham khảo

10.1152/ajprenal.2000.279.4.F636

10.1152/ajprenal.2000.279.5.F841

10.1016/0167-0115(92)90049-Z

10.1097/00041552-199701000-00006

10.1161/01.CIR.0000092888.63239.54

10.1038/nrg1272

10.1016/j.amjhyper.2004.02.022

10.1016/0196-9781(93)90097-Z

10.1161/01.HYP.26.6.1138

10.1152/ajpheart.1995.269.1.H313

10.1590/S0100-879X2004000800017

10.1161/01.HYP.0000085220.53285.11

10.1161/01.HYP.17.5.720

10.1016/j.tem.2004.03.001

10.1093/eurheartj/ehi114

10.1161/01.CIR.0000153269.07762.3B

10.1161/01.HYP.0000124669.02394.72

10.1007/s11906-005-0086-0

10.1159/000078713

10.1161/01.HYP.31.1.362

10.1097/00005344-200104000-00011

10.1161/01.HYP.37.4.1141

10.1210/en.2002-220787

10.1038/nature00786

10.1161/01.HYP.31.4.912

10.3317/jraas.2004.041

10.1038/sj.bjp.0706039

10.1161/01.RES.87.1.1

10.1016/S0022-2828(03)00177-9

10.1172/JCI118452

Feng YH, Zhou L, Qiu R, and Zeng R. Single mutations at Asn295 and Leu305 in the cytoplasmic half of TM7 of the AT1 Receptor induce promiscuous agonist specificity for angiotensin II fragments. A pseudo-constitutive activity. Mol Pharmacol 2005.

Ferrario CM. Angiotension-(1–7) and antihypertensive mechanisms. J Nephrol 11: 278–283, 1998.

Ferrario CM. Myocardial infarction increases ACE2 expression in rat and humans. Eur Heart J 26: 1141, 2005.

Ferrario CM, Averill DB, Brosnihan KB, Chappell MC, Diz DI, Gallagher PE, and Tallant EA. Angiotensin-(1–7): its contributions to arterial pressure control mechanisms. In: Handbook of Experimental Pharmacology: Angiotensin, edited by Unger T and Scholkens BA. Heidelberg, Germany: Springer-Verlag, 2004, vol. 1, p. 478–518.

10.1161/01.HYP.18.3_Suppl.I126

10.1161/01.HYP.30.3.535

10.1161/CIRCULATIONAHA.104.510461

Ferrario CM, Jessup J, Gallagher PE, Averill DB, Brosnihan KB, Tallant EA, Smith R, and Chappell MC. Differential effects of renin angiotensin system blockade on renal angiotensin converting enzyme 2 gene expression and activity. Kidney Int. In press.

10.1016/S0895-7061(02)02268-9

10.1161/01.HYP.38.3.665

10.1590/S0100-879X2002000900009

10.1161/01.HYP.28.1.104

10.1016/0895-7061(95)00221-A

10.2174/1568016043356255

10.1016/S0167-0115(02)00032-0

10.1161/01.HYP.17.2.139

10.1172/JCI119367

Hanley MR, Cheung WT, Hawkins P, Poyner D, Benton HP, Blair L, Jackson TR, and Goedert M. The mas oncogene as a neural peptide receptor: expression, regulation and mechanism of action. Ciba Found Symp 150: 23–38, 1990.

10.1016/S0014-5793(02)03640-2

10.1152/ajpheart.00068.2005

10.1038/nature03712

10.1161/01.HYP.0000124667.34652.1a

10.1161/01.HYP.36.3.417

10.1161/01.HYP.31.2.699

10.1161/01.HYP.31.1.356

10.1097/00005344-200007000-00015

10.1038/335437a0

Jaiswal N, Tallant EA, Jaiswal RK, Diz DI, and Ferrario CM. Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involved. J Pharmacol Exp Ther 265: 664–673, 1993.

10.1038/sj.jhh.1001646

10.1016/S0960-9822(98)70114-9

10.1152/physiolgenomics.00255.2004

10.1097/01.hjh.0000160217.86597.b6

10.1080/1042517021000021608

10.1161/01.CIR.0000160867.23556.7D

10.1016/S0006-8993(98)00384-9

Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, Huan Y, Yang P, Zhang Y, Deng W, Bao L, Zhang B, Liu G, Wang Z, Chappell M, Liu Y, Zheng D, Leibbrandt A, Wada T, Slutsky AS, Liu D, Qin C, Jiang C, and Penninger JM. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med 2005.

10.3317/jraas.2000.041

10.1161/01.HYP.0000035396.27909.40

10.1002/path.1670

10.1152/ajpendo.00402.2004

10.1161/01.HYP.29.1.394

10.1161/01.CIR.0000013847.07035.B9

10.1097/00004872-199606000-00017

10.1385/ENDO:18:3:239

10.1161/01.HYP.25.6.1260

10.1161/01.HYP.25.4.796

10.1152/ajpregu.00210.2002

10.1016/S0196-9781(03)00062-7

10.1016/j.regpep.2004.10.013

10.1161/01.HYP.4.2.177

10.1016/S0196-9781(99)00031-5

10.1161/01.HYP.0000100423.24330.96

10.1152/ajpregu.00263.2003

10.1097/00041552-200503000-00011

10.1042/BJ20040634

10.1161/01.HYP.11.2.153

10.1161/01.HYP.15.2_Suppl.I121

10.1016/S0167-0115(00)00138-5

10.1152/physiolgenomics.00227.2003

10.1073/pnas.1432869100

10.1097/00005344-199016004-00006

10.1073/pnas.85.11.4095

10.1016/j.jpeds.2004.03.055

10.1161/01.HYP.33.1.207

10.1161/01.HYP.0000090322.55782.30

10.1161/01.HYP.34.4.950

10.1152/ajpheart.00941.2004

10.1161/01.HYP.0000060689.38912.CB

10.1080/02713680490517944

10.1016/S1357-2725(02)00273-X

10.1074/jbc.M311191200

10.1042/bst0310723

10.1016/S0165-6147(00)01994-5

10.1139/y02-021

10.1097/00004872-200111000-00010

10.1385/ENDO:16:2:117

10.1074/jbc.M200581200

10.1124/jpet.300.1.324

10.1016/0024-3205(93)90108-F

10.1161/01.HYP.0000063886.71596.C8

10.1016/S0167-0115(99)00005-1

10.1161/01.HYP.32.3.496

10.1161/01.CIR.0000143077.23367.18

10.1161/01.HYP.19.6.692

10.1093/eurheartj/ehi043

10.1161/01.CIR.0000094734.67990.99